BUZZ-U.S. STOCKS ON THE MOVE-Longeveron, Novavax, Telsa

Reuters04-15

U.S. stock index futures rose on Monday after Wall Street witnessed a bruising sell-off in the previous session on the back of disappointing earnings from some big U.S. banks, while escalating tensions in the Middle East made investors wary.

At 7:33 ET, Dow e-minis were up 0.47% at 38,419. S&P 500 e-minis were up 0.49% at 5,192.75, while Nasdaq 100 e-minis were up 0.55% at 18,279.25.

The top two NYSE percentage gainers premarket :

** Medical Properties Trust , up 14.3%

** Kuke Music Holding , up 11.4%

The top two NYSE percentage losers premarket :

** Osisko Development , down 9.3%

** Molina Healthcare , down 7.6%

The top Nasdaq percentage gainer premarket :

** Longeveron , up 47.3%

The top three Nasdaq percentage losers premarket :

** Marinus Pharmaceuticals , down 74.5%

** Nextplat , down 19.3%

** Apple : down 0.8% premarket Dips on losing top phonemaker status to Samsung

** Telsa : down 1.3% premarket Telsa pares premarket losses on media reports of job cuts

** Snap One : up 30.3% premarket Surges on Resideo's $1.4 bln buyout deal

** Novavax : up 2.3% premarket Rises after hedge fund Shah Capital recommends two new director candidates

** Paccar : up 0.2% premarket JP Morgan raises PT on strength from newer models

** Lockheed Martin : up 1.6% premarket JP Morgan upgrades Lockheed Martin to 'overweight'

** Piedmont Lithium : up 22.8% premarket Jumps on getting permit for North Carolina project

** Neumora Therapeutics : down 13.7% premarket Falls after US FDA puts schizophrenia drug study on hold

** Blackbaud : up 2.7% premarket Gains on Clearlake Capital's raised buyout offer

(Compiled by Annett Mary Manoj in Bengaluru)

((AnnettMary.Manoj@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment